The global vascular access systems market is evaluated at US$ 4.744 billion for the year 2019 growing at a CAGR of 6.27% reaching the market size of US$ 7.259 billion by the year 2026.
Venous or arterial access is obtained through vascular access systems. Vascular Access Devices are medical equipment used to get ingress the bloodstream to supply medicines, administer fluids, nutritional components, and collection of blood vessels and their products. These vascular access tubes are made from latex, silicon, and other substances. The procedure involves placing rigid plastic tubes into blood vessels such as the basilic vein and subclavian vein to perform diagnostic tests and treatments such as chemotherapy, intravenous antibiotic treatment, and intravenous feeding. It includes blood sampling, blood transfusion, fluid infusion, and central venous pressure readings. The vascular access catheter devices are also significantly used in the case of chemotherapies.
The blood is obtained from or delivered to a person’s bloodstream over a continuous period through different vascular access devices such as cannulae, catheters, peripherals, and ports. The procedure relieves patients from the continuous stress of needles and offers a painless method to draw blood or provide medication. The rising global prevalence of diseases such as kidney failure, diabetes, and cancer which involve the transfer of blood to and from the human body is positively impacting the demand for vascular access systems. High infection risk associated with vascular access devices and stringent government approval regulations restrains the growth of the vascular access systems market.
The prevalence of diabetes, increasing rates of road accidents, and an increasing number of surgical procedures are expected to drive the market. Increasing demand for advanced techniques, such as needleless administration of drugs is also a vital driver for this market. Every day many healthcare workers handle drugs in hospitals and other healthcare centers. Despite precaution measures availability, there remains a risk of exposure to these drugs during procedures. Such exposures may occur through, ingestion, absorption, accidental inhalation, or dermal contact of a minimal amount of these drugs which may lead to a variety of health problems.
The advent of COVID-19 had a positive impact on the market of vascular access systems as it became an integral part of the treatment procedures that were followed during the period to cure the patients. Moreover, WHO declared COVID-19 a pandemic as the increase in the number of cases was exponential in the initial months. The medical authorities advised the hospitals and other such medical institutions to stock up the requirements to never run out of supplies during the treatments, which in turn, increased the demand for vascular access systems in the year 2020.
Innovations in the sector have brought down the costs of these products in recent years and the trend is expected to continue during the forecast period.
Global Vascular Access Systems Market Scope:
|Market size value in 2019||US$4.744 billion|
|Market size value in 2026||US$7.259 billion|
|Growth Rate||CAGR of 6.27% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Product, Application, End-User, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Edwards Lifesciences Corporation, Baxter International Inc., C.R. Bard, Inc., Fresenius Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex Incorporated, Medtronic PLC, B.Braun Melsungen AG, Smiths Medical, Biomerics|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the vascular access systems market?
A1. The global vascular access systems market is projected to grow at a CAGR of 6.27% over the forecast period.
Q2. What will be vascular access systems market size by 2026?
A2. The vascular access systems market is projected to reach a total market size of US$7.259 billion by 2026.
Q3. What is the size of the global vascular access systems market?
A3. Vascular Access Systems market was valued at US$4.744 billion in 2019.
Q4. Who are the major players in the vascular access systems market?
A4. Major industry players profiled as part of the vascular access systems market report are Edwards Lifesciences Corporation, Baxter International Inc., C.R. Bard, Inc., Fresenius Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex Incorporated among others.
Q5. What factors are anticipated to drive the vascular access systems market growth?
A5. The rising global prevalence of diseases such as kidney failure, diabetes, and cancer which involve the transfer of blood to and from a human body is positively impacting the demand for vascular access systems.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Vascular Access Systems Market Analysis, by Product
5.2. Peripherally Inserted Central Catheter (PICC)
5.3. Non-Tunneled Central Catheter
5.4. Tunneled Catheter
5.5. Port Catheter
6. Vascular Access Systems Market Analysis, by Application
6.2. Intravenous Antibiotic Treatment
6.3. Blood Transfusion
6.4. Long-Term IV Feeding
7. Vascular Access Systems Market Analysis, by End-user
7.2. Hospitals and Clinics
7.3. Ambulatory Surgical Centers
7.4. Catheterization Labs
8. Vascular Access Systems Market Analysis, by Geography
8.2. North America
8.3. South America
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.6. Asia Pacific
8.6.4. South Korea
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Edwards Lifesciences Corporation
10.2. Baxter International Inc.
10.3. C.R. Bard, Inc.
10.4. Fresenius Medical Care AG & Co. KGaA
10.5. Becton, Dickinson and Company
10.6. Teleflex Incorporated
10.7. Medtronic PLC
10.8. B.Braun Melsungen AG
10.9. Smiths Medical
Edwards Lifesciences Corporation
C.R. Bard, Inc.
Fresenius Medical Care AG & Co. KGaA
Becton, Dickinson and Company
B.Braun Melsungen AG
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.